This site is intended for healthcare professionals

Novinky z letošního nejvýznamnějšího setkání onkologů 2022

Cabozantinib (C) plus atezolizumab (A) or C alone in patients (pts) with advanced non–small cell lung cancer (aNSCLC) previously treated with an immune checkpoint inhibitor (ICI): Results from Cohorts 7 and 20 of the COSMIC-021 study.

Joel W. Neal

Stanford University, Stanford Cancer Institute, Palo Alto, CA

Abstract number: #9005   Authors: Joel W. Neal Stanford University, Stanford Cancer Institute, Palo Alto, CA Joel W. Neal, Armando Santoro, Santiago Viteri, Santiago Ponce Aix, Bruno Fang, Farah Louise Lim, Ryan D. Gentzler, Jerome H. Goldschmidt, Polina Khrizman, Erminia Massarelli, Shiven B. Patel, Sonam Puri, Ramu Sudhagoni, Christian Scheffold, Dominic Curran, Enriqueta Felip  ...

Zpět

Cystická fibróza 1/2025

02 | 07 | 2025

Antiinfectives News 1/2025

27 | 06 | 2025

Paediatric News 1/2025

03 | 04 | 2025

Již brzy vyjde nové číslo časopisu Paediatric News.




Partneři projektu